Drug
Early anticoagulation
Early anticoagulation is a pharmaceutical drug with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
2(67%)
Phase Distribution
Ph phase_4
1
33%
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(3)
Detailed Status
Recruiting2
Enrolling by invitation1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
Phase 4
Trials by Phase
Phase 41 (33.3%)
N/A2 (66.7%)
Trials by Status
enrolling_by_invitation133%
recruiting267%
Recent Activity
2 active trials
Showing 3 of 3
recruitingnot_applicable
Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation 2
NCT07139314
recruitingnot_applicable
Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation
NCT07139301
enrolling_by_invitationphase_4
Optimal PeriproCeduraL AnticOagulation in Structural Transseptal Interventions
NCT05305612
Clinical Trials (3)
Showing 3 of 3 trials
NCT07139314Not Applicable
Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation 2
NCT07139301Not Applicable
Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation
NCT05305612Phase 4
Optimal PeriproCeduraL AnticOagulation in Structural Transseptal Interventions
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3